These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 7229828)
1. Depyrogenation of a parenteral solution by ultrafiltration. Abramson D; Butler LD; Chrai S J Parenter Sci Technol; 1981; 35(1):3-7. PubMed ID: 7229828 [No Abstract] [Full Text] [Related]
2. Depyrogenation, sterilization and deproteination of radiopharmaceuticals with an ultrafilter. Suzuki K; Tamate K; Nakayama T Nucl Med Commun; 1984 Jan; 5(1):19-25. PubMed ID: 6543925 [No Abstract] [Full Text] [Related]
3. Depyrogenation of pharmaceutical solutions using submicron and ultrafilters. Brown S; Fuller AC J Parenter Sci Technol; 1993; 47(6):285-7. PubMed ID: 8120732 [TBL] [Abstract][Full Text] [Related]
4. [Methods for ensuring the apyrogenic quality of injection solutions in hospital pharmacies]. Eroshevskiĭ AA; Khveshchuk PF; Riabykh LD Voen Med Zh; 1991 Mar; (3):59-60. PubMed ID: 1853599 [TBL] [Abstract][Full Text] [Related]
5. [The purification of dialysate]. Urano H; Suzuki M; Hirasawa Y Nihon Rinsho; 1991 Dec; 49 Suppl():307-13. PubMed ID: 1808274 [No Abstract] [Full Text] [Related]
6. Depyrogenation by endotoxin removal with positively charged depth filter cartridge. Hou KC; Zaniewski R J Parenter Sci Technol; 1990; 44(4):204-9. PubMed ID: 2213428 [TBL] [Abstract][Full Text] [Related]
7. Introduction to papers on mycoplasmology presented at a Parenteral Drug Association mycoplasma workshop. Potts BJ Biologicals; 2010 Mar; 38(2):181-2. PubMed ID: 20079662 [No Abstract] [Full Text] [Related]
8. Final inline filters. Millam DA Am J Nurs; 1979 Jul; 79(7):1272-3. PubMed ID: 256449 [No Abstract] [Full Text] [Related]
10. [Depyrogenation in key manufacturing processes of Reduning injection]. Li M; Xu Y; Song J; Wang Y; Pan Y; Wang Z; Xiao W; Liu T Zhongguo Zhong Yao Za Zhi; 2011 Mar; 36(6):663-5. PubMed ID: 21710723 [TBL] [Abstract][Full Text] [Related]
11. [Particle contamination of infusion solution and equipment]. Hübner G Klin Anasthesiol Intensivther; 1977; (14):70-3. PubMed ID: 926692 [No Abstract] [Full Text] [Related]
12. Design and operation of an in-house pyrogen test facility. Armistead RL; Taylor NL Bull Parenter Drug Assoc; 1977; 31(1):14-7. PubMed ID: 831894 [No Abstract] [Full Text] [Related]
13. Reduction of pyrogens--application of molecular filtration. Cradock JC; Guder LA; Francis DL; Morgan SL J Pharm Pharmacol; 1978 Mar; 30(3):198-9. PubMed ID: 24702 [No Abstract] [Full Text] [Related]
14. Removal of pyrogens by filtration? Turco SJ Am J Health Syst Pharm; 1999 Mar; 56(5):477. PubMed ID: 10096712 [No Abstract] [Full Text] [Related]
15. [Material contamination of infusion solutions]. Klaus E Klin Anasthesiol Intensivther; 1977; (14):54-69. PubMed ID: 926691 [No Abstract] [Full Text] [Related]
20. [Summary of the discussion on the subject of: "technical problems in the production and use of infusion solutions"]. Klin Anasthesiol Intensivther; 1977; (14):95-105. PubMed ID: 926695 [No Abstract] [Full Text] [Related] [Next] [New Search]